RLAY is trading 4.2% up now at $19.34, extending a strong multi-week rally. - Today's upward movement is driven by the company's inclusion in the Russell 3000E Growth Benchmark. - Investors also remain focused on encouraging data for lead candidate zovegalisib and the recent $275 million capital raise from a stock offering.